Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
This study was presented in podium/oral format at the Society of Surgical Oncology (SSO) 2022 International Conference on Surgical Cancer Care, Dallas, TX, March 9–12, 2022. The preparation of this study was supported in part by NIH/NCI Cancer Center Support Grant No. P30 CA008748 to Memorial Sloan Kettering Cancer Center. Dr. Monica Morrow has received honoraria from Exact Sciences and Roche. Dr. Chau Dang has research support from Roche-Genentech, PUMA, and Daiichi Sankyo, and has received honoraria from PUMA, Daiichi Sankyo, Pfizer, Novartis, and Evicore. All other authors have no conflict of interest disclosures to report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Williams, A.D., Dang, C.T., Sevilimedu, V. et al. ASO Visual Abstract: Neoadjuvant Chemotherapy for Breast Cancer in the Elderly—Are We Accomplishing Our Treatment Goals?. Ann Surg Oncol 29, 8014–8015 (2022). https://doi.org/10.1245/s10434-022-12282-w
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12282-w